VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,000 | -56.5% | 42,476 | +14.0% | 0.00% | – |
| Q2 2023 | $913,914 | -65.6% | 37,257 | -67.4% | 0.00% | -100.0% |
| Q1 2023 | $2,657,597 | -26.6% | 114,207 | -20.2% | 0.00% | -50.0% |
| Q4 2022 | $3,621,532 | +377.1% | 143,087 | +263.2% | 0.00% | – |
| Q3 2022 | $759,000 | -31.1% | 39,395 | -8.9% | 0.00% | -100.0% |
| Q2 2022 | $1,101,000 | -3.8% | 43,240 | -2.8% | 0.00% | 0.0% |
| Q1 2022 | $1,144,000 | -43.3% | 44,478 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $2,019,000 | -7.0% | 48,226 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $2,171,000 | -2.6% | 49,902 | +5.9% | 0.00% | 0.0% |
| Q2 2021 | $2,228,000 | +3.9% | 47,140 | +12.7% | 0.00% | 0.0% |
| Q1 2021 | $2,145,000 | +75.1% | 41,830 | -8.5% | 0.00% | 0.0% |
| Q4 2020 | $1,225,000 | +15.9% | 45,728 | +48.5% | 0.00% | 0.0% |
| Q3 2020 | $1,057,000 | +10.3% | 30,803 | +31.7% | 0.00% | 0.0% |
| Q2 2020 | $958,000 | +1014.0% | 23,393 | +839.1% | 0.00% | – |
| Q1 2020 | $86,000 | +152.9% | 2,491 | -11.4% | 0.00% | – |
| Q4 2019 | $34,000 | – | 2,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |